BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20525892)

  • 1. Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.
    Chen X; Hamano R; Subleski JJ; Hurwitz AA; Howard OM; Oppenheim JJ
    J Immunol; 2010 Jul; 185(1):174-82. PubMed ID: 20525892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.
    Chen X; Subleski JJ; Kopf H; Howard OM; Männel DN; Oppenheim JJ
    J Immunol; 2008 May; 180(10):6467-71. PubMed ID: 18453563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
    Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
    J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.
    Chen X; Wu X; Zhou Q; Howard OM; Netea MG; Oppenheim JJ
    J Immunol; 2013 Feb; 190(3):1076-84. PubMed ID: 23277487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
    Zhou Q; Hu Y; Howard OM; Oppenheim JJ; Chen X
    Cytokine; 2014 Jan; 65(1):56-64. PubMed ID: 24080164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
    Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
    Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients.
    Yan F; Du R; Wei F; Zhao H; Yu J; Wang C; Zhan Z; Ding T; Ren X; Chen X; Li H
    Cancer Immunol Immunother; 2015 Nov; 64(11):1475-85. PubMed ID: 26280204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.
    Chen X; Subleski JJ; Hamano R; Howard OM; Wiltrout RH; Oppenheim JJ
    Eur J Immunol; 2010 Apr; 40(4):1099-106. PubMed ID: 20127680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.
    Hamano R; Huang J; Yoshimura T; Oppenheim JJ; Chen X
    Eur J Immunol; 2011 Jul; 41(7):2010-20. PubMed ID: 21491419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
    Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
    Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis.
    Chen X; Nie Y; Xiao H; Bian Z; Scarzello AJ; Song NY; Trivett AL; Yang D; Oppenheim JJ
    Sci Rep; 2016 Sep; 6():32834. PubMed ID: 27601345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4
    He T; Chen Y; Yang D; Islam MS; Chou CK; Liu J; Faustman DL; Oppenheim JJ; Chen X
    Cell Oncol (Dordr); 2023 Feb; 46(1):167-177. PubMed ID: 36369606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients.
    Engku Abd Rahman ENS; Irekeola AA; Shueb RH; Mat Lazim N; Mohamud R; Chen X; Ghazali L; Awang NMSH; Haron A; Chan YY
    Cytokine; 2023 Oct; 170():156341. PubMed ID: 37657236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
    Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
    Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 discriminates heat shock protein 60-induced FOXP3+ CD4+ T cells with a regulatory phenotype.
    de Kleer I; Vercoulen Y; Klein M; Meerding J; Albani S; van der Zee R; Sawitzki B; Hamann A; Kuis W; Prakken B
    J Immunol; 2010 Aug; 185(4):2071-9. PubMed ID: 20631311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathway(s) of TNFR2 required for the immunoregulatory effect of CD4
    He T; Zhao Y; Zhao P; Zhao L; Zakaria J; Wang K
    Int Immunopharmacol; 2022 Jul; 108():108823. PubMed ID: 35623290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2.
    Jiang M; Yang Y; Niu L; Li P; Chen Y; Liao P; Wang Y; Zheng J; Chen F; He H; Li H; Chen X
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36319063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
    Front Immunol; 2018; 9():1274. PubMed ID: 29922294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.